490 episodes

Relevant, evidence based, and practical information for medical students, residents, and practicing healthcare providers regarding all things women’s healthcare! This podcast is intended to be clinically relevant, engaging, and FUN, because medical education should NOT be boring! Welcome...to Clinical Pearls.

Dr. Chapa’s Clinical Pearls‪.‬ Dr. Chapa’s Clinical Pearls

    • Science

Relevant, evidence based, and practical information for medical students, residents, and practicing healthcare providers regarding all things women’s healthcare! This podcast is intended to be clinically relevant, engaging, and FUN, because medical education should NOT be boring! Welcome...to Clinical Pearls.

    NEW ACOG ADVISORY: JAN 2022

    NEW ACOG ADVISORY: JAN 2022

    In the ACOG Practice Bulletin #106, which was released in 2009, the use of maternal supplemental oxygen for fetal heart rate tracing correction is mentioned. In that original bulletin, it states “despite inadequate data to support its use” consideration can be given to supplemental maternal oxygen for category II or III fetal heart rate tracings. However, within the last 7 years, an ever-growing body of evidence has proven that supplemental oxygen for fetal heart rate pattern abnormalities is not only ineffective but may actually be harmful to the premature fetus. Now, as of January 2022, we now have new guidance on this. Find out how and why the ACOG has now changed its original opinion.

    • 6 min
    OB HTN UPDATES (BIG CMQCC Recommendations).

    OB HTN UPDATES (BIG CMQCC Recommendations).

    Hypertensive disorders in pregnancy are a large contributor to maternal mortality. Maternal mortality rates for chronic hypertension in pregnancy have increased 15-fold over the last 4 decades! The California Maternal Quality Care Collaborative (CMQCC) has been a leading authority in the Pregnancy Hypertensive space. In the session, we will review BIG updates from the CMQCC. Should we aggressively treat chronic hypertension in pregnancy? What about treating nonsevere gestational hypertension? Are you familiar with the new Cardiology subspecialty of “Cardio- Obstetrics“? Let’s cover all this information… NOW!

    • 19 min
    New Data on Periods After Covid Vaccination

    New Data on Periods After Covid Vaccination

    Concerns about a possible association between COVID-19 vaccination and abnormal menstrual cycles may lead to vaccine hesitancy. Social media sites have claimed that cycles are affected, although temporarily, after vaccination. Is this true? In the session, we will summarize a soon to be released publication out of Obstetrics and Gynecology which helps clarify this issue. We will also highlight a press release from January 6, 2022 from a major news outlet which seemingly appears to distort those results.

    • 12 min
    Repeat CS timing with 2+ CSs

    Repeat CS timing with 2+ CSs

    Women with multiple prior low-transverse CSs show a trend toward increased risk of rupture compared with a single prior CS. While some have advocated planned repeat CS at 39 weeks as in patients with a SINGLE previous cesarean, planned repeat CD at 38 weeks is likely to be associated with a lower risk of uterine rupture. Yet, there is no consensus on best practice. In this session, we will summarize a new AJOG publication (Jan 2022) that raises some interesting and clinically meaningful data regarding the timing of repeat CS in women with 2+ prior cesareans (Shinar et al. Timing of cesarean delivery in women with 2+ previous cesarean deliveries. AJOG; Jan 2022).

    • 11 min
    Zmax Beats E-Mycin for PPROM Care

    Zmax Beats E-Mycin for PPROM Care

    In 1997, Mercer et al first published their data on antibiotic use for PPROM latency. With IV Erythromycin shortages, Zmax is a known substitute. New data (EPUB December 2021) now points to Zithromax’s validated clinical advantage over Erythromycin in this protocol. In this session, we will review this soon to be released publication in AJOG.

    • 12 min
    Not All LARCS Are Equal!

    Not All LARCS Are Equal!

    Traditionally, physicians have informed patients that long acting reversible contraceptives are “just as effective“ as female sterilization. While as a Class that statement is correct, not all individual LARCS have the same efficacy; one in particular beats all other birth control methods, hands-down. Do you know which one? In this session we will review key facts regarding female sterilization and review the individual efficacies of long acting reversible contraceptives. We will also review the historic “math model” for female sterilization.

    • 17 min

Top Podcasts In Science

Samuel Salameh
Hidden Brain
Kerning Cultures Network
Neil deGrasse Tyson
SWR
Alexander Lasch

You Might Also Like

Brown Ob/Gyn Residency
The Curbsiders Internal Medicine Podcast
American Academy of Family Physicians
JAMA Network
The Clinical Problem Solvers
Obstetrics & Gynecology (Green Journal)